Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

Blood Neoplasia(2025)10.1016/j.bneo.2025.100159Source: DataRank Database

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib is a research paper published in Blood Neoplasia (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.00)OA: goldTopics (11)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Jessica M. Stempel ORCID,Rory M. Shallis ORCID,Scott F. Huntington ORCID,Amer M. Zeidan ORCID,Natalia Neparidze ORCID

Live enrichment

PubMed:41216598 PMC:PMC12597058 OpenAlex:https://openalex.org/W4413323300

National Institutes of Health

Grant: T32CA233414

National Cancer Institute

Grant: N01-PC-35136

National Cancer Institute

Grant: N01-PC-35139

University of Southern California

Grant: U55/CCR921930-02

University of Southern California

Grant: N02-PC-15105

NCI NIH HHS

Grant: N02 PC015105

NCI NIH HHS

Grant: N01 PC035136

NCI NIH HHS

Grant: N01 PC035139

Frederick A. DeLuca Foundation

YALE UNIVERSITY SCHOOL OF MEDICINE

California Department of Public Health

Edward P. Evans Foundation

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bneo.2025.100159

publisherhttps://doi.org/10.1016/j.bneo.2025.100159

publisherhttps://api.elsevier.com/content/article/PII:S2950328025000949?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2950328025000949?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41216598

Fields of Study

Myeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and Treatments

Keywords

RuxolitinibMedicineInternal medicineMyelofibrosisOncologyMyeloproliferative DisordersDermatologyBone marrow

Sustainable Development Goals

SDG 0: Zero hunger

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

FAIR Checklist

Authors (11)

Funding (12 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)